39S

Volume 75, Number 1S

14. In patients undergoing CEA, we recommend statin
therapy.
15. In patients undergoing CEA, we recommend
continuing aspirin therapy.
16. In patients undergoing CEA, during the perioperative
period we recommend individualizing the continued
use of dual antiplatelet therapy based on speciÔ¨Åc indications (eg, cardiac).
17. In patients with increased cardiac risk factors undergoing